BioCentriq Expands Operations and Secures Cell Therapy Manufacturing Facility in Princeton, NJ

URLhttps://www.prnewswire.com/news-releases/biocentri
SourcePR Newswire
Date Published12/17/2024

Additional Reshoring Information:

Company/Division name BioCentriq
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2024
Domestically, the work will be done:In-house
Capital investment ($):12
City reshored to:Princeton
State(s) reshored to:NJ
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredcell therapy
Find Reshoring Articles